Valuation Cuorips Inc.

Stocks

Delayed Japan Exchange 19:33:41 2026-11-05 EST			5-day change	1st Jan Change
6,090.00 ^JPY	-7.02%		-17.28%	+0.83%

09-27	Cuorips Inc. announced that it has received ¥2.9999677 billion in funding from JIC Venture Growth Investments Co., Ltd.	CI
09-11	Cuorips Inc. announced that it expects to receive ¥2.9999677 billion in funding from JIC Venture Growth Investments Co., Ltd.	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2024	2025	2026
Market Cap ¹	29,126	67,173	57,885
Change	-	130.63%	-13.83%
Enterprise Value (EV) ¹	23,544	62,380	53,986
Change	-	164.96%	-13.46%
P/E	-43x	-103x	-56.3x
PBR	4.91x	12.2x	12.2x
PEG	-	16.48x	-1x
Capitalization / Revenue	1,266x	384x	273x
EV / Revenue	1,024x	356x	255x
EV / EBITDA	-45.5x	-121x	-54.1x
EV / EBIT	-40x	-106x	-49.9x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-85.84	-80.48	-124.5
Distribution rate	-	-	-
Net sales ¹	23	175	212
EBITDA ¹	-518	-514	-997
EBIT ¹	-588	-590	-1,081
Net income ¹	-632	-644	-1,022
Net Debt ¹	-5,582	-4,793	-3,899
Reference price ²	3,695.00	8,310.00	7,010.00
Nbr of stocks (in thousands)	7,882	8,083	8,258
Announcement Date	6/27/24	6/20/25	6/24/26

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CUORIPS INC.	-	-	-	-	382M
ELI LILLY AND COMPANY	41.5x	14.02x	31.15x	0.48%	1,263B
JOHNSON & JOHNSON	40.44x	6.79x	19.1x	1.93%	665B
ABBVIE INC.	37.93x	8.6x	17.74x	2.35%	521B
ROCHE HOLDING AG	21.34x	5.18x	12.9x	2.53%	387B
MERCK & CO., INC.	99.59x	6.08x	25.91x	2.26%	371B
NOVARTIS AG	23.46x	6.01x	14.51x	2.66%	310B
ASTRAZENECA PLC	24.81x	4.95x	13.96x	1.76%	293B
AMGEN INC.	29.96x	7.59x	13.11x	2.11%	259B
GILEAD SCIENCES, INC.	-41.77x	7.6x	47.71x	1.89%	216B
Average	30.81x	7.42x	21.79x	2%	428.58B
Weighted average by Cap.	36.76x	8.84x	22.92x	1.69%